NIH-funded research R01 grant

Understanding how racism affects cancer pain treatment equity

Official title: A multi-level examination of the influences of racism on cancer pain equity

Funded at Dana-Farber Cancer Inst · NIH-11041138 · Data updated 2026-11-12

This study is looking at how different racial and ethnic groups of cancer patients experience pain management, especially when it comes to using opioids, and aims to find ways to improve pain relief for everyone by understanding their unique challenges.

More Cancer Pain research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionDana-Farber Cancer Inst
NIH-funded
Lab location1 site (Boston, United States)
Project startFebruary 21, 2024
Project endJanuary 31, 2029
Funding year2025
Award (this year)$653,887
NIH project number5R01CA279414-02
Project IDNIH-11041138 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include cancer patients, particularly those who are Black or Hispanic, and those experiencing significant pain.

Less likely to help

Patients who are not experiencing cancer pain or who do not belong to racial or ethnic minority groups may not benefit from this research.

What this research studies

This research aims to explore the racial and ethnic disparities in the management of cancer pain, particularly focusing on how these disparities affect the use of opioids among cancer patients. By analyzing data from a large population of cancer patients, the study seeks to identify the key factors contributing to inequities in pain management. The goal is to develop a multi-level intervention that addresses these disparities and improves pain treatment for affected populations. Patients will be involved in understanding their experiences and the barriers they face in receiving adequate pain relief.

Why it matters

Potential benefit: If successful, this research could lead to more equitable pain management practices for cancer patients of color, improving their quality of life.

How similar studies have gone: Previous studies have highlighted disparities in opioid management among cancer patients, indicating that this research builds on existing knowledge but aims to address gaps in understanding and intervention.

Where this research is happening

  • Dana-Farber Cancer Inst
    Boston, United States
    Active

Researchers

  • Principal investigator: Enzinger, Andrea C — Dana-Farber Cancer Inst
  • Study coordinator: Enzinger, Andrea C

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.